BioMarin Pharmaceutical Inc. buy Morgan Stanley
Start price
26.04.24
/
50%
€75.64
Target price
26.04.25
€104.69
Performance (%)
0.82%
Price
06.05.24
€76.26
Summary
This prediction is currently active. Since the start of the prediction for BioMarin Pharmaceutical Inc. the price has only changed by 0.82%. This prediction currently runs until 26.04.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
BioMarin Pharmaceutical Inc. | -0.470% |
iShares Core DAX® | 0.476% |
iShares Nasdaq 100 | 1.290% |
iShares Nikkei 225® | 1.300% |
iShares S&P 500 | 0.829% |
Comments by Morgan_Stanley for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Morgan Stanley from $115.00 to $112.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€113.91
01.08.24
01.08.24
-4.34%
06.05.24
06.05.24